Resources by service
Bespoke fully automated packaging solution helps secure success of Global Phase III Mega Trial
When drug manufacturers have established key findings from Phase I and Phase II studies, such as safe dosage, side effects and patient response to new therapeutic interventions, it’s time to move on to a Phase III trial.
Phase III studies can involve thousands of patients, across multiple clinical sites and across multiple global locations. With this brings several supply and demand-based challenges. One of these challenges relates to packaging and, more specifically, the design materials, operating forecasts and equipment needed to effectively and compliantly process and package clinical supplies.
To learn how one global pharmaceutical company overcame a number of packaging challenges arising from the scale and complexity of their Phase III clinical trial, download our case study by completing the form.
*By submitting your information you acknowledge that you have read the privacy statement and you consent to our processing the data in accordance with that privacy statement. We may, from time to time, send you material relevant to your interests. If you change your mind at any time about wishing to receive material from us, you can send an email to email@example.com. Every email we send you will also include an unsubscribe link so you can unsubscribe from our marketing list.